|
시장보고서
상품코드
2057528
키메라 항원 수용체 NK 세포 치료 시장 : 기회 및 전략(-2035년)Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Global Market Opportunities And Strategies To 2035 |
||||||
The Business Research Company
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.
가격
※ 부가세 별도
한글목차
영문목차
키메라 항원 수용체 NK 세포 치료는 키메라 항원 수용체(CAR) 발현을 통해서 암세포를 인식 및 파괴하도록(듯이) 유전자 변형 또는 증식 시킨 NK 세포(NK) 세포를 이용하는 첨단세포 면역요법 일종입니다. CAR-NK 요법은 NK 세포가 본래 가지는 세포 상해능과 유전자 변형에 의해서 부여된 종양 특이성을 조합하는 것으로, 악성 세포에 대한 표적 면역 반응을 가능하게 합니다.
키메라 항원 수용체 NK 세포 치료 시장은 각종암, 특히 혈액 악성 종양이나 고형 종양 치료에 사용되는 CAR-NK 세포 치료, 사업체(조직, 개인 사업주, 파트너십)에 의한 판매량으로 구성되어 있어 재발, 난치성, 또는 치료 저항성 질환을 가지는 환자에게 투여됩니다. 이 요법은 통상, 화학요법, 방사선 요법, 수술, 또는 조혈모세포 이식등의 기존 치료법이 효과가 없는지, 적합하지 않는 경우에 이용됩니다. 또한 치료 성과를 높이기 위해, CAR-NK 세포치료는 치료 초기 단계에서의 도입, 기타 면역치료와의 병용도 검토되고 있습니다.
인더스트리 4.0과 지능형 제조
CAR-NK 세포 치료제 시장의 주요 기업들은 수작업에 의한 개방형 공정에 대한 의존도를 줄이면서 재현성과 처리량을 향상시키기 위해 산업화, 폐쇄형, 자동화가 가능한 GMP 제조를 점점 더 우선시하고 있습니다. 이를 통해 표준화되고 확장 가능한 기성품(off-the-shelf) 생산이 가능해져 동종 CAR-NK 프로그램의 상용화를 위한 준비가 강화되었습니다. CAR-NK 개발 기업은 작업자에 따른 편차를 최소화하면서 대규모 생산 로트 전체에 걸쳐 보다 높은 수준의 공정 제어와 반복성을 실현할 수 있습니다. 예를 들어, 2024년 6월, 유전자 변형 자연살해 세포 치료제를 개발하는 미국 기반 임상 1상 단계의 바이오 제약기업인 Nkarta, Inc.는 Ntrust-1의 시작을 발표했습니다. 이는 난치성 루푸스 신염 환자를 대상으로 CD19를 표적으로 하는 자사의 기허가 동종 키메라 항원 수용체 자연살해 세포치료제 'NKX019'를 평가하는 미국 내 첫 임상시험입니다. 첫 환자 스크리닝이 시작되었고, 초기 임상 데이터는 2025년에 얻을 수 있을 것으로 예측됩니다. 또한, 전신성 피부경화증, 특발성 염증성 근병증, 혈관염 등의 자가면역질환을 대상으로 NKX019를 시클로포스파미드로 림프구 제거요법 후 0일, 3일, 7일 투여 후 NKX019를 평가하는 'Ntrust-2' 시험의 임상시험계획(IND)이 승인되었다고 발표했습니다. 이는 원래 림프종에 최적화된 NKX019의 고처리량 및 일관성 있는 제조 플랫폼을 기반으로 하며, 독성을 줄이면서 B세포 제거를 확장할 수 있고, 필요에 따라 반복 투여할 수 있는 가능성을 제공합니다.
유형별 키메라 항원 수용체 NK 세포 치료 시장 시장 세분화에서 가장 큰 기회는 입양된 자연살해(NK) 세포 치료제 부문에서 발생하며, 2030년까지 세계 연간 매출액은 4억 5,730만 달러에 달할 것으로 예측됩니다. 세포원별로 분류한 키메라 항원 수용체 NK 세포 치료 시장 세분화에서 가장 큰 기회는 말초혈액 유래 자연살해세포 부문에서 발생하며, 2030년까지 전 세계 연간 매출액은 3억 9,000만 달러에 달할 것으로 예측됩니다.
자주 묻는 질문
목차
제1장 주요 요약
제2장 목차
제3장 표 리스트
제4장 그래프 리스트
제5장 보고서 구성
제6장 시장 특징
제7장 주요 시장 동향
제8장 세계의 키메라 항원 수용체 NK 세포 치료 시장 : 성장 분석 및 전략적 분석 프레임워크
제9장 세계의 키메라 항원 수용체 NK 세포 치료 시장 : 규모 및 성장 분석
제10장 세계의 키메라 항원 수용체 NK 세포 치료 시장 : 시장 세분화
제11장 키메라 항원 수용체 NK 세포 치료 시장 : 지역별 및 국가별 분석
제12장 아시아태평양 시장
제13장 동남아시아 시장
제14장 북미 시장
제15장 서유럽 시장
제16장 남미 시장
제17장 동유럽 시장
제18장 중동 시장
제19장 아프리카 시장
제20장 기업 개요
제21장 기타 주요 기업 및 혁신 기업
제22장 경쟁 대시보드
제23장 시장에서 주목 받는 스타트업
제24장 최근 동향 : 키메라 항원 수용체 NK 세포 치료 시장
제25장 향후 전망과 잠재적 가능성 분석
제26장 부록
AJYChimeric antigen receptor-natural killer (CAR-NK) cell therapy is an advanced form of cellular immunotherapy that utilizes natural killer (NK) cells engineered or expanded to recognize and destroy cancer cells through the expression of chimeric antigen receptors (CARs). CAR-NK therapy combines the innate cytotoxic capabilities of NK cells with the tumor-targeting specificity conferred by genetic modification, enabling targeted immune responses against malignant cells.
The chimeric antigen receptor-natural killer (CAR-NK) cell therapy market consists of sales by entities (organizations, sole traders and partnerships) of CAR-NK cell therapy used in the treatment of various cancers, particularly hematological malignancies and solid tumors, and is administered to patients who may have relapsed, refractory, or treatment-resistant disease. The therapy is typically used when conventional treatments such as chemotherapy, radiation therapy, surgery, or hematopoietic stem cell transplantation are ineffective or unsuitable. CAR-NK cell therapy may also be explored earlier in treatment or in combination with other immunotherapies to enhance therapeutic outcomes.
Industry 4.0 & Intelligent Manufacturing
Major companies in the CAR-NK cell therapy market are increasingly prioritizing industrialized, closed-system, and automation-enabled GMP manufacturing to improve reproducibility and throughput while reducing reliance on manual, open processing. This is strengthening commercialization readiness of allogeneic CAR-NK programs by enabling standardized, scalable off-the-shelf production. CAR-NK developers can achieve greater process control and reproducibility across large manufacturing runs while minimizing operator-dependent variability. For example, In June 2024, Nkarta, Inc., a United States-based Phase 1 clinical-stage biopharmaceutical company developing engineered natural killer cell therapies, announced the initiation of Ntrust-1, the first United States-based clinical trial evaluating its off-the-shelf, allogeneic chimeric antigen receptor natural killer therapy NKX019 targeting CD19 for patients with refractory lupus nephritis, with the first patient entering screening and initial clinical data expected in 2025. The company also announced clearance of an Investigational New Drug application for the Ntrust-2 trial to evaluate NKX019 in autoimmune diseases, including systemic sclerosis, idiopathic inflammatory myopathy, and vasculitis, using a Days 0, 3, and 7 dosing regimen following cyclophosphamide lymphodepletion, building on NKX019's high-throughput and consistent manufacturing platform originally optimized for lymphoma to enable scalable B-cell depletion with reduced toxicity and the potential for repeat dosing on demand.
The top opportunities in the chimeric antigen receptor-natural killer (CAR-NK) cell therapy market segmented by type will arise in the adoptive natural killer (NK) cell therapy segment, which will gain $457.3 million of global annual sales by 2030. The top opportunities in the chimeric antigen receptor-natural killer (CAR-NK) cell therapy market segmented by cell source will arise in the peripheral blood-derived natural killer cells segment, which will gain $309.0 million of global annual sales by 2030.
Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global chimeric antigen receptor-natural killer (CAR-NK) cell therapy market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for chimeric antigen receptor-natural killer (CAR-NK) cell therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chimeric antigen receptor-natural killer (CAR-NK) cell therapy market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider chimeric antigen receptor-natural killer (CAR-NK) cell therapy market; and compares it with other markets.
The report covers the following chapters
- Introduction And Market Characteristics Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
- Key Trends Highlights the major trends shaping the global market. This section also highlights likely future technologies and developments in the market.
- Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Regional And Country Analysis Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
- Market Segmentation Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by type, by cell source, by application and by end user in the market. historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
- Regional Market Size And Growth Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies Details on the startups, company profiles of other major and innovative companies in the market.
- Competitive Benchmarking Briefs on the financials comparison between major players in the market.
- Competitive Dashboard Briefs on competitive dashboard of major players.
- Key Mergers And Acquisitions Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Recent Developments Information on recent developments in the market covered in the report.
- Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Appendix This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
- Conclusions And Recommendations This section includes recommendations for chimeric antigen receptor-natural killer (CAR-NK) cell therapy providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Markets Covered:
- 1) By Type: Adoptive Natural Killer (NK) Cell Therapy; Genetically Engineered Natural Killer Cell Therapy; Other Types
- 2) By Cell Source: Peripheral Blood-Derived Natural Killer Cells; Cord Blood-Derived Natural Killer Cells; Induced Pluripotent Stem Cell (Ipsc)-Derived Natural Killer Cells; Natural Killer Cell Lines
- 3) By Application: Solid Tumors; Hematological Malignancies; Other Applications
- 4) By End User: Hospitals; Cancer Research Institutes; Biotechnology And Pharmaceutical Companies
- Companies Mentioned: ImmunityBio Inc.; PersonGen Biomedicine; Fate Therapeutics Inc.; Nkarta Therapeutics Inc.; Senti Biosciences, Inc.
- Countries: China; Australia; India; Indonesia; Japan; South Korea; Taiwan; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
- Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; chimeric antigen receptor-natural killer (CAR-NK) cell therapy indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Table of Contents
1 Executive Summary
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
- 6.1 General Market Definition
- 6.2 Summary
- 6.3 Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Definition And Segmentations
- 6.4 Market Segmentation By Type (Adoptive Natural Killer (NK) Cell Therapy, Genetically Engineered Natural Killer Cell Therapy And Other Types)
- 6.5 Market Segmentation By Cell Source (Peripheral Blood-Derived Natural Killer Cells, Cord Blood-Derived Natural Killer Cells, Induced Pluripotent Stem Cell (Ipsc)-Derived Natural Killer Cells And Natural Killer Cell Lines)
- 6.6 Market Segmentation By Application (Solid Tumors, Hematological Malignancies And Other Applications)
- 6.7 Market Segmentation By End User (Hospitals, Cancer Research Institutes And Biotechnology And Pharmaceutical Companies)
7 Major Market Trends
- 7.1 Key Technologies & Future Trends
- 7.1.1 Biotechnology, Genomics & Precision Medicine
- 7.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 7.1.3 Artificial Intelligence & Autonomous Intelligence
- 7.1.4 Internet of Things, Smart Infrastructure & Connected Ecosystems
- 7.1.5 Industry 4.0 & Intelligent Manufacturing
- 7.2 Major Trends
- 7.2.1 Focus On iPSC-Derived, Off-The-Shelf CAR-NK Platforms For Precision-Built Cell Products
- 7.2.2 Emergence Of Chemotherapy-Free / Reduced-Conditioning CAR-NK Regimens Enabled By Cytokine Biology
- 7.2.3 Focus On Closed-System, GMP-Industrialized Manufacturing For Allogeneic CAR-NK Scale-Up
- 7.2.4 Development Of Rapid IND-Ready CAR-NK Pipelines Enabled By GMP-Integrated CDMO Manufacturing
8 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Growth Analysis And Strategic Analysis Framework
- 8.1 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy PESTEL Analysis
- 8.1.1 Political
- 8.1.2 Economic
- 8.1.3 Social
- 8.1.4 Technological
- 8.1.5 Environmental
- 8.1.6 Legal
- 8.2 End User Analysis (B2B)
- 8.2.1 Hospitals
- 8.2.2 Cancer Research Institutes
- 8.2.3 Biotechnology And Pharmaceutical Companies
9 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Size And Growth Analysis
- 9.1 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
- 9.1.1 Market Drivers 2025 - 2030
- 9.1.2 Market Restraints 2025 - 2030
10 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market Segmentation
- 10.1 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 10.2 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 10.3 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 10.4 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 10.5 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Sub-Segmentation Of Adoptive Natural Killer Cell Therapy, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 10.6 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Sub-Segmentation Of Genetically Engineered Natural Killer Cell Therapy Market, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 10.7 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Sub-Segmentation Of Other Types, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
11 Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Regional and Country Analysis
- 11.1 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 11.2 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
12 Asia-Pacific Market
- 12.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 12.2 Asia Pacific Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.3 Asia Pacific Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.4 Asia Pacific Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.5 China Market
- 12.5.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 12.5.2 China Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.5.3 China Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.5.4 China Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.6 India Market
- 12.6.1 India Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.6.2 India Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.6.3 India Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.7 Japan Market
- 12.7.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 12.7.2 Japan Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.7.3 Japan Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.7.4 Japan Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.8 Australia Market
- 12.8.1 Australia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.8.2 Australia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.8.3 Australia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.9 South Korea Market
- 12.9.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 12.9.2 South Korea Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.9.3 South Korea Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.9.4 South Korea Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.10 Taiwan Market
- 12.10.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 12.10.2 Taiwan Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.10.3 Taiwan Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 12.10.4 Taiwan Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
13 South East Asia Market
- 13.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 13.2 South East Asia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.3 South East Asia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.4 South East Asia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.5 Indonesia Market
- 13.5.1 Indonesia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.5.2 Indonesia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 13.5.3 Indonesia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
14 North America Market
- 14.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 14.2 North America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.3 North America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.4 North America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.5 USA Market
- 14.5.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 14.5.2 USA Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.5.3 USA Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.5.4 USA Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.6 Canada Market
- 14.6.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 14.6.2 Canada Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.6.3 Canada Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 14.6.4 Canada Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
15 Western Europe Market
- 15.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 15.2 Western Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.3 Western Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.4 Western Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.5 UK Market
- 15.5.1 UK Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.5.2 UK Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.5.3 UK Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.6 Germany Market
- 15.6.1 Germany Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.6.2 Germany Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.6.3 Germany Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.7 France Market
- 15.7.1 France Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.7.2 France Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.7.3 France Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.8 Italy Market
- 15.8.1 Italy Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.8.2 Italy Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.8.3 Italy Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.9 Spain Market
- 15.9.1 Spain Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.9.2 Spain Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 15.9.3 Spain Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
16 South America Market
- 16.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 16.2 South America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.3 South America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.4 South America Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.5 Brazil Market
- 16.5.1 Brazil Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.5.2 Brazil Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 16.5.3 Brazil Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
17 Eastern Europe Market
- 17.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 17.2 Eastern Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.3 Eastern Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.4 Eastern Europe Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.5 Russia Market
- 17.5.1 Russia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.5.2 Russia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 17.5.3 Russia Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
18 Middle East Market
- 18.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 18.2 Middle East Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.3 Middle East Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 18.4 Middle East Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
19 Africa Market
- 19.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
- 19.2 Africa Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.3 Africa Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Cell Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
- 19.4 Africa Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
20 Company Profiles
- 20.1 ImmunityBio Inc. (Company Overview, Products and Services, Business Strategy, Financial Overview)
- 20.2 PersonGen Biomedicine (Company Overview, Products and Services, Business Strategy, Financial Overview)
- 20.3 Fate Therapeutics (Company Overview, Products and Services, Business Strategy, Financial Overview)
- 20.4 Nkarta Therapeutics Inc. (Company Overview, Products and Services, Business Strategy, Financial Overview)
- 20.5 Senti Biosciences, Inc. (Company Overview, Products and Services, Business Strategy, Financial Overview)
21 Other Major And Innovative Companies
- 21.1 Artiva Biotherapeutics (Company Overview, Products and Services)
- 21.2 Century Therapeutics (Company Overview, Products and Services)
- 21.3 Catamaran Bio (Company Overview, Products and Services)
- 21.4 Wugen Therapeutics Inc. (Company Overview, Products and Services)
- 21.5 Acepodia (Company Overview, Products and Services)
- 21.6 ONK Therapeutics (Company Overview, Products and Services)
- 21.7 Glycostem Therapeutics (Company Overview, Products and Services)
- 21.8 Takeda (MD Anderson) (Company Overview, Products and Services)
- 21.9 Affimed (Company Overview, Products and Services)
- 21.10 Gamida Cell (Company Overview, Products and Services)
- 21.11 Indapta Therapeutics (Company Overview, Products and Services)
- 21.12 Chimeric Therapeutics (Company Overview, Products and Services)
- 21.13 Cartherics Pty Ltd (Company Overview, Products and Services)
- 21.14 Nuwacell Biotechnologies Co., Ltd. (Company Overview, Products and Services)
- 21.15 SMT Bio Co. Ltd. (Company Overview, Products and Services)
22 Competitive Dashboard
23 Upcoming Startups In the Market
24 Recent Developments In Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy
- 24.1 Emergence Of Sustained Complete Responses With Off-The-Shelf CAR-NK Cell Therapy
25 Future Outlook and Potential Analysis
- 25.1 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market In 2030 - Countries Offering Most New Opportunities
- 25.2 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market In 2030 - Segments Offering Most New Opportunities
- 25.3 Global Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell Therapy Market In 2030 - Growth Strategies
- 25.3.1 Market Trend Based Strategies
- 25.3.2 Competitor Strategies
26 Appendix
- 26.1 Geographies Covered
- 26.2 Market Data Sources
- 26.3 Research Methodology
- 26.4 Currencies
- 26.5 The Business Research Company
- 26.6 Copyright and Disclaimer
